Dr Ankur Srivastava
PhD, MBChB, BSc, MRCP, SCE (Gastro)
"Working at Spire Bristol Hospital gives me an opportunity to work in a reputable hospital and deliver first class care to my patients in a supportive and patient centered environment."
I am a consultant in general gastroenterology, liver medicine and endoscopy at North Bristol Trust. I was awarded my PhD (Doctor of Philosophy) from the University College London for advancing research in the field of early detection of chronic liver disease and I completed my training in the North East London rotation.
I specialise in general gastroenterology and liver medicine. I perform both diagnostic and therapeutic gastroscopy and colonoscopy. I am an accredited endoscopy trainer. I am available for virtual consultations upon request.
I am an experienced endoscopist and have performed over 2,000 gastroscopies and 1,000 colonoscopies.
I am the departmental lead for the Royal College of Physicians Improving Quality in Liver Services (IQILS) accreditation scheme. This was a national accreditation project that involved co-ordinating a multi-professional group to assess the standard of care delivered by the service, identify both good practice and areas for improvement and then develop and implement service improvement plans. The North Bristol Liver Unit became the second unit in the country to achieve accreditation in November 2021 and we were commended for the quality of the leadership and evidence presented. Specific standards that were covered included leadership and operational delivery, person centred care, risk and patient safety, clinical effectiveness, workforce development and systems to support service delivery.
In addition to my clinical work, I am delighted to be the departmental lead for Research at the trust.
I am also proud to have been elected onto the British Society of Gastroenterology Liver Section Committee to help develop and promote national service strategy.
I am a medical assessor for the Royal College of Physicians 'Improving Quality in Liver Disease' scheme. I visit other units and assess them against national standards.
I am a principal investigator and sub-investigator for a number of industry sponsored and non-commercial clinical trials for patients with inflammatory bowel disease and liver disease.
I have a research interest in identifying strategies to promote the earlier detection of chronic liver disease, having recently completed a PhD in this subject area. This forms an ongoing part of my academic work, and I am involved on a national level. My research studies focused on the utility of non-invasive liver fibrosis tests in patients at risk of chronic liver disease and translating their use into clinical pathways with a particular focus on primary care use. This work led to a new understanding of the use of these novel tests to improve patient outcomes.
Some of the principal treatments carried out by Dr Ankur Srivastava at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Bristol Hospital.
BSc Pharmacology / University of Bristol / 2003
Bachelor of Medicine
MBChB and MRCP / Royal College of Physicians / 2006
Bachelor of Surgery
PhD / University College London / 2022
Doctor of Philosophy
General Medical Council, UK
Medical Defence Union
Member of Royal College of Physicians
Member of British Society of Gastroenterology (BSG)
Member of British Association of Study of the Liver (BASL)
Member of European Association of Study of the Liver (EASL)
I am the departmental lead for the Royal College of Physicians Improving Quality in Liver Services (IQILS) accreditation scheme. The North Bristol Liver Unit became the second unit in the country to achieve accreditation in November 2021 and we were commended for the quality of the leadership and evidence presented. I am also the Gastroenterology and Hepatology Research Lead at North Bristol Trust. The department is active in a number of investigator-initiated and commercial research trials.
Prospective evaluation of a primary care referral pathway for patients with NAFLD. Journal of Hepatology (2019)
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD). The Lancet Gastroenterology and Hepatology (2022)
Consultant Gastroenterologist, Hepatologist and Endoscopist - Southmead Hospital, North Bristol Trust.
Outside of work, I enjoy spending my time with my wonderful wife and two beautiful young boys.